<DOC>
	<DOC>NCT02212106</DOC>
	<brief_summary>This is a study to assess the safety of a bioCSL split virion, inactivated Trivalent Influenza Virus vaccine containing the 2014/2015 Northern Hemisphere strains of vaccine in children aged 5 years to less than 9 years. Comparison will be made to a licensed Quadrivalent Influenza Virus vaccine that complies with the FDA recommendations for the 2014/2015 influenza season in the US.</brief_summary>
	<brief_title>A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to &lt; 9 Years</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Males or females aged 5 to less than 9 years at the time of first study vaccination. The subject's parent or guardian to provide written informed consent and be willing and able to adhere to all protocol requirements. In good health, as determined by medical history and a targeted physical examination (if warranted). Known hypersensitivity to a previous dose of Influenza Virus Vaccine or allergy to eggs or any components of the study vaccines. Clinical signs of significant active infection or an elevated oral temperature at study entry. A clinically significant medical or psychiatric condition. A history of seizures or febrile convulsions or GuillainBarr√© syndrome. Vaccination with a seasonal or experimental influenza virus vaccine in the 6 months preceding study entry. Vaccination with a licensed vaccine within 14 days preceding study entry, or planning to be vaccinated with another licensed vaccine before the study exit evaluation. Currently receiving systemic glucocorticoid therapy (excluding intraarticular, topical or inhaled preparations) or have received such therapy within the 3 months preceding study entry. Currently receiving immunoglobulins and/or any blood products or have received such treatment within the 3 months preceding the administration of the study vaccine. Currently receiving treatment with warfarin or other anticoagulants.</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>